PNC FINANCIAL SERVICES GROUP, INC. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,554,910
-59.1%
119,740
-2.1%
0.00%
-55.6%
Q2 2023$11,146,177
+174.9%
122,351
+99.1%
0.01%
+125.0%
Q1 2023$4,054,232
+28.6%
61,465
+0.8%
0.00%
+33.3%
Q4 2022$3,151,983
-20.4%
60,955
+5.2%
0.00%
-25.0%
Q3 2022$3,958,000
+51.5%
57,946
+0.3%
0.00%
+33.3%
Q2 2022$2,612,000
-10.9%
57,752
+0.1%
0.00%0.0%
Q1 2022$2,932,000
+379.1%
57,699
+345.6%
0.00%
+200.0%
Q4 2021$612,000
+206.0%
12,948
+113.7%
0.00%
Q3 2021$200,000
-46.8%
6,058
+1.8%
0.00%
Q2 2021$376,000
+47.5%
5,9480.0%0.00%
Q1 2021$255,000
-25.0%
5,9480.0%0.00%
Q4 2020$340,000
+89.9%
5,9480.0%0.00%
Q3 2020$179,000
+9.1%
5,948
+18.8%
0.00%
Q2 2020$164,000
+22.4%
5,008
+0.2%
0.00%
Q1 2020$134,000
-13.0%
5,0000.0%0.00%
Q4 2019$154,000
-26.7%
5,000
-42.9%
0.00%
Q3 2019$210,000
-16.3%
8,760
-11.2%
0.00%
Q2 2019$251,000
-9.1%
9,860
-30.3%
0.00%
Q1 2019$276,000
+122.6%
14,140
+50.7%
0.00%
Q4 2018$124,0000.0%9,380
+35.2%
0.00%
Q3 2018$124,000
-23.5%
6,940
-6.0%
0.00%
Q2 2018$162,0007,3800.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders